SAGE-547

brexanolone · Sage Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for SAGE-547, covering 2019-05-02 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus